Milford Funds’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.8M Sell
24,761
-7,985
-24% -$8.1M 0.48% 47
2025
Q4
$35.2M Buy
+32,746
New +$31.3M 0.69% 44

Other funds holding LLY

Milford Funds's LLY Position: Q1 2026 in Review

Milford Funds reduced its Eli Lilly (LLY) stake by 24% in Q1 2026, selling an estimated $8.1M and leaving 24,761 shares worth $22.8M. The position accounts for 0.48% of the portfolio, ranked #47.

Milford Funds first reported a position in LLY in Q4 2025 and has held it in 2 quarters since. The position peaked at $35.2M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Milford Funds held 24,761 shares of Eli Lilly worth $22.8M as of Q1 2026.
  • Milford Funds sold 7,985 Eli Lilly shares in Q1 2026, an estimated $8.1M.
  • Eli Lilly made up 0.48% of Milford Funds's portfolio in Q1 2026, its #47 holding.
  • Milford Funds first reported a position in Eli Lilly in Q4 2025 and has held it in 2 quarters since.
  • Milford Funds's Eli Lilly position peaked at $35.2M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Milford Funds's 13F filing for Q1 2026, filed 14 May 2026.